November 1, 2017:
New FDA Mandate Sends
This Device Into EVERY
Restaurant in America
A new device is emerging that’s promising to...
Stop every pathogen from e. coli, salmonella, and bird flu... to life-threatening superbugs
Unleash a $20 billion wave of wealth...
Send the one tiny 75-cent stock with all the patents on it soaring to dizzying heights...
All starting with a critical technology rollout on November 1
A new FDA-mandated device is quickly spreading to every city in America...
It detects dangerous pathogens before they spread...
And before they lead to major outbreaks that threaten thousands — if not millions of Americans...
- E. Coli
- Bird Flu
- Mad Cow
- Even antibiotic-resistant bacteria we call superbugs!
As these epidemics ravage the public, costing billions each year for cities and businesses...
A groundbreaking solution has just been developed in a mysterious facility 40 miles east of Silicon Valley.
You’re looking at the Livermore Lawrence Laboratory, a top-secret military site — home to major inventions like Google Earth and the Human Genome Project...
Where scientists have just pioneered what could prove to be the lab’s biggest breakthrough EVER.
A next-generation device that can stop deadly epidemics in their tracks in just one hour.
Backed by millions of dollars from the Defense Department, Homeland Security, and the DOE...
This device is ushering in a revolution in epidemic prevention, promising to save millions of lives. And save businesses billions of dollars. Here it is...
It doesn’t look like much, but what it can do is nothing short of breathtaking.
In a matter of minutes, it tells you how clean your water is. How clean your food is.
If and what kind of bacteria is in it, how dangerous it is, and what to do about it.
And it does so with undisputed, dead-on accuracy.
Nothing else is capable of achieving virtually real-time biometric updates like this!
In fact, it’s so impressive, so powerful, and so one-of-a-kind...
That the FDA just mandated the testing this device goes into every restaurant supply chain in America...
Not just restaurants either...
You name it!
Everywhere food or water may be at risk of deadly bacteria...
Where there’s a potential public health risk...
And where viruses, germs, or pathogens can potentially spread...
This device is about to enter guns blazing, thanks to a new FDA mandate.
But the best part is...
“The Pentagon scientist behind this device just handed
investors a massive opportunity...”
investors a massive opportunity...”
Perhaps the biggest of 2017 or even the next decade.
In order to fulfill the FDA’s mandate, and to get this device into the public’s hands...
He founded a tiny company — holding all the patents — that just went IPO earlier this year.
Since then, its share price already jumped 174%.
But that’s just for starters...
Right now this tiny firm is valued at a mere $20 million.
But on November 1, that will all change.
On that day, this device will spread to businesses and cities nationwide.
A mandated rollout that will quickly disrupt a $20 billion market... in just a matter of months.
That’s over 1,000 times this firm’s value!
If it captures even a tiny fraction of this market, its stock would be several times what it’s trading for now.
And the FDA mandate is putting this device on track to dominate the whole thing!
Now, for a brief window, you can buy in for just 75 cents. And I do mean brief...
Because as it quickly spreads to hospitals, restaurants, and factories everywhere...
Large firms are poised to jump in for a piece of the action, starting a fierce buyout war...
One that could drive this company’s share price from 75 cents to $5... $25... and beyond. Just in 2017!
There’s no time to waste.
Today, I’ve assembled all the details on this ground-floor opportunity, including its company profile, name, and ticker symbol.
You’ll see a full display of what its patented device can do, how it works...
The FDA mandate that will put it into factories, restaurants, and hospitals EVERYWHERE.
And why $122 may be a very conservative estimate for this company’s share price.
In short, you’ll get everything you need to position yourself immediately for the biggest profit opportunity of the year.
But first, allow me to answer one question:
How can I have such confidence this tiny company is poised for a lucrative buyout, making investors rich?
Because it won’t be the first time it happened.
In fact, get this:
Every single technology to come out of Livermore has made investors a fortune... no exceptions.
EVERY Company Coming Out of This Military Site
Has Made Investors Rich
- Chromosome Painting
— A cancer and chromosome disorder detection device invented at
Livermore that’s gone on to support a billion-dollar market. Vysis
recognized this value and licensed the technology, and was then acquired
by Abbott Laboratories for $355 million in 2001.
- Droplet digital PCR (ddPCR)
— Invented at Livermore for detecting rare cancerous mutations and
providing very accurate gene copy number counts. The technology was used
to found QuantaLife, which was later purchased for $162M in 2011.
- Rapid PCR Technology — Invented at Livermore to significantly shorten the time for genetic analysis. The technology was used to found Cepheid, which manufactures instruments for rapid detection of infectious diseases and some cancers. Cepheid was recently acquired by Danaher for $4 billion in 2016.
And that’s just a few examples.
Every single time a technology or invention from Livermore goes to the private sector...
It creates hundreds of millions, or even billions in wealth.
That’s because in its square-mile campus, it employs 6,000 of the world’s best scientists...
Working on innovations in not just military, but energy, health care, and transportation.
And now over 100 currently-operating companies owe their success to the lab’s inventions.
Take Google Earth, now patented by Digital Globe — a $2 billion company.
Or the Human Genome Project, responsible for the rise of the biotech boom.
There’s the RDRAM memory chip, now patented by Rambus — a multibillion-dollar company.
One auto safety device is now standard protocol for almost every car in America.
It keeps going...
There’s a crash simulation software that now saves the auto industry $14 billion every year.
And a laser technology that saves aerospace makers like Boeing hundreds of millions per year.
The list goes on and on.
They’re all Livermore inventions that have made investors downright filthy rich.
Now, all the evidence you’ll see here today will point to one thing:
This FDA-mandated device is the NEXT billion-dollar technology emerging out of Livermore.
And investors on the ground floor will once again make fantastic wealth.
Again, how can I be so certain about its major wealth potential?
The Pentagon Scientist Behind This Device Has
One Big Winner After Another
Because the Pentagon scientist behind it has done it before... with multiple life-saving technologies under his belt.
One of them is an anthrax detection device backed by Homeland Security.
Another is a plague detection device backed by the Defense Department.
Then there’s a flu detection device backed by the National Institutes of Health.
In fact, this scientist invented the ddPCR technology that detects rare cancerous mutations — the one bought out for $162 million!
Devices that save lives... prevent outbreaks... stop terror attacks.
Those are the sorts of inventions this scientist is famous for!
But this one device is set to be even bigger — exponentially bigger.
You see, his last three inventions were new versions of the exact same technology...
Now this scientist has invented the next generation of this device...
And while his first three versions are being used by government to stop crises...
Thanks to the FDA’s mandate, this “fourth-generation” device will instead disrupt a $20 billion consumer market...
Making investors who buy in immediately on the ground floor fantastically rich.
To get you started, I’ll share with you the name of the 75-cent company with all the patents on it.
But first, allow me to answer something that you might be wondering...
What is this FDA mandate? Why will this device soon be everywhere because of it?
And could it really take over a $20 billion market?
Let me explain.
The FDA Move That Makes
This Device Mandatory
Previously, companies were only made to respond to outbreaks like e. coli. They only had to clean up outbreaks.
But due to a new congressional bill, known as the “Food Safety Modernization Act”...
Companies must take serious measures to prevent them from EVER happening.
This bill includes...
- 3x more frequent FDA inspections
- Required records for all testing results
- Inspection of foreign food supplies
Just to name a few things.
The FDA is implementing these rules from now to the end of 2018.
A regulatory blitzkrieg that will force the food industry to dramatically overhaul its practices. And not just the food industry...
- Meat processing
- Cruise lines
- School cafeterias
The list goes on and on.
The problem is, most of these companies haven’t started preparing for the FDA’s new rules.
The technology is simply not yet available to uphold them, much less at a reasonable cost.
Fortunately, one little device — that I’ve shared with you today — will allow the food industry to do just that... and without spending an arm and a leg.
In fact, even without the FDA mandate, businesses would scramble to get their hands on it. Don’t believe me?
Take Chipotle, which lost $6 BILLION in value from e. coli and other food outbreaks...
It could have saved ALL of this money, with a device that costs LESS THAN $100,000.
That’s just 0.00006% of the money lost by shareholders, including their execs!
In other words, they could have saved $60,000 for every $1 spent on this device.
And that’s just one example...
Outbreaks are wreaking havoc on companies like...
- General Mills
- Trader Joe’s
- Archer Daniels Midland
All told, the food industry loses $55 BILLION every single year from pathogen epidemics.
When you consider this sort of cash, the price tag for this device is beyond a no-brainer.
In fact, the money it could save is just one part of the equation.
Just think:It could save brands from losing their reputations over embarrassing food recalls...
It could save 48 million Americans from illness — even death — due to pathogens in food or water.
It could save workers from massive job losses when companies lose BILLIONS.
Bottom line: this is a technology that saves lives, jobs, and companies!
Can you see why the FDA mandated this technology?
Why companies would pay a fortune for this device — even without the mandate?
And why investors who buy in now — before it spreads to every major restaurant in America — will see historic fortunes, starting November 1?
It’s gearing up for the disruption of the $20 billion market that already exists for safety testing...
Food, water, fisheries, vet clinics — these are just some of the biggest markets it’s entering.
Markets that spend to the tune of $20 billion per year on safety testing.
But what’s the upside potential for you?
Why This Stock Could Surge
from 75 Cents to $122
That’s roughly $1 billion in sales per year.
Given an average industry price/sales ratio of 5.8... and factor in a total share count of 49 million...
The share price would be fairly valued at $122!
And remember: that’s just a tiny 5% of this entire market.
With the FDA mandate, it could dominate the entire industry without question!
In short, the upside potential is virtually unlimited.
But you might be wondering: how does this device work? Let me explain.
Detects Any Deadly Pathogen —
in Less Than 1 Hour!
It’s designed so even a novice could use it. It couldn’t be easier.
Simply load the cartridge with the sample substance — be it food, water, or otherwise...
And it will automatically process the results, scanning for no less than 22 different pathogens.
Or, if you choose, customize the test for one or several things you’re looking for.
Within one hour, a full report is generated on the pathogen levels and their exact amounts.
It also auto-analyzes the results, detecting the threat levels with stunning accuracy.
This is work normally done by molecular biologists! And anyone can use it — no training needed.
At an industrial poultry farm, a worker could test a sample of water that all the chickens drink from.
And the machine will report, in less than one hour, if there’s any strain of bird flu.
The same goes for produce.
At a central warehouse, where lettuce and other vegetables are washed and prepped for shipping...
This device can be used to analyze runoff water from washing, detecting e. coli, listeria, and more.
And it gets these results in under one hour.
And it’s incredibly cheap in industrial device terms — less than $115,000.
In fact, the cost of food safety testing nowadays runs companies up to 300 times that much.
How can the company sell it for so little — and still make a lot of money?
It’s the razor blade model.
Each time a test is done a new cartridge is needed.
They’re one of a kind. They’re disposable. And the company charges $55 each time. But it makes it for around $1.50, giving it incredible margins over 95%.
With this device, a single company may run hundreds of tests each year. Year after year.
With hundreds of thousands of companies running this many tests...
It’s a massive flood of revenue that will NEVER run out. And it’s over 95% profit margin.
That all sounds great, but how can we be sure it REALLY works?
The World’s Top Engineering
Firm Built This Device
While it was developed at the national military laboratory... It’s been built by the top minds at Boston Engineering.
With a staff of over 70 engineers, they’ve created technology for the likes of...
Fortune 50 companies, including Pepsi
The largest medical device companies in the world, including 3M
And government departments like Homeland Security, the Navy, and the National Oceanic and Atmospheric Administration
In short, when the big boys want a technology to be built...
When they want to make sure their device is free from defects and runs like clockwork...
They go to Boston Engineering.
Also, remember, this is not the first, second, or third go-around for this device.
It’s the fourth.
The U.S. government spent over $20 million developing this technology.
One of them monitors air quality in New York’s Penn Station, detecting bioterror threats.
They’ve also made investors incredibly rich, with massive multimillion-dollar buyouts.
The same scientist who holds all the patents is now behind this version too.
And now, with the tiny company he founded, you can buy into its $20 BILLION market opportunity for under $1 — but only if you act immediately...
To get you started, I’ll share with you all the details you need in just one moment.
Before I do, let me be clear:
This Pentagon scientist is NOT the only heavy hitter with a track record of minting millionaires.
This entire company is staffed with military insiders...
Guys who’ve turned tiny companies into billion-dollar acquisitions...
Some even specialize in technology that stops epidemic outbreaks...
It’s a dream team unlike any other I’ve seen in a company.
Own This Company
The company’s president has a legendary track record.
Before joining this company, he was a Senior Advisor at Canaccord, where he raised capital for new companies... mostly medical device startups.
He was VP of Auryn Resources, where he won a major capital fusion from Goldcorp — the world’s second-largest gold miner.
And he was also a consultant to Cayden Resources, which was bought out by Agnico Eagle for $205 million.
But that’s just for starters...
Just a take a look at this incredible management team... including:
A retired lt. colonel, microbiologist, and director of the Air Force’s largest infectious disease testing program
The director of the BioWatch program at the Lawrence Livermore Laboratory who has chaired proposal reviews at the CDC and National Institutes of Health
An executive at the billion-dollar medical device company Boston Science Corporation, and founder of two successful medical device startups
“Dream Teams” at companies like this are once in a lifetime.
We may never see a pairing of great minds, insiders, and experts like this again.
This is how you make a fortune in tiny companies like this — follow the management.
While I can’t say for sure how high shares will ultimately go...
I can say with 100% confidence that the 75 cents they’re currently trading at is incredibly cheap.
Remember, November 1 is when this rollout begins, but you won’t want to wait until then.
Already, shares have surged 174% since this company IPO’d in March.
At this rate, it could get into the thousands percentile range — even before November.
Why wait to buy it later, when shares are above $5 or even $50, when you can buy right now for just 75 cents?
To get you started immediately, I’ve compiled a full dossier on this ground-floor opportunity called...
The FDA-Mandated Device: Earn 12,500% on the
Technology That Ends Outbreaks
Here’s a quick preview of what it includes:
The company’s name and ticker symbol.
Thorough company profile based on firsthand investigation, including intel you won’t find on CNBC, or even in industry journals.
“Off-the-cuff” footage of their company’s operations, including my interviews with its executives
Demonstrations, examples, and full details on how its technology works
Overview of the FDA mandate that will force this device into dozens of industries
The $20 BILLION market opportunity up for grabs
The coming catalysts you won’t find elsewhere, including the November 1 rollout
November Fox Business Announcement
Set to Launch Shares
Oh yeah, before I forget, this November — just as the device is launching into dozens of industries...
The company’s President is scheduled to make an appearance on a Fox Business program...
One of the most widely watched programs on television.
In front of 85 million viewers minimum, he’ll detail the technology, the FDA mandate...
And he’ll announce the technology’s rollout, beginning the takeover of a $20 billion market.
Now, on a typical day, this company trades at a very low volume — about 8,000 shares.
That’s why these stocks are so tiny — nobody knows about them!
But it’s not hard to imagine how that will change.
When it appears on Fox Business it’s not hard to imagine typical investors will begin a feeding frenzy...
One that will launch shares into the stratosphere...
If just 1% of the Fox Business audience, 850,000 people, bought only one share each...
It would explode the trading volume by a staggering 10,000%.
And that’s a very conservative estimate, especially since...
There could be millions of more buyers... and each of these shares trades at 75 cents!
The gains on that single day could be truly life-altering!
I want you to be fully positioned in advance before.
Which is why I include all the details on this urgent opportunity in your dossier... entirely free of charge.
All I ask in return is that you take a risk-free test drive of my premium research advisory service, Early Advantage.
Join the Club
Hi. I'm Nick Hodge.
I'm an investment analyst here at Angel Publishing in Baltimore, Maryland.
I'm also editor of Nick Hodge's Early Advantage, the resource for big profits from little-known breakthroughs and disruptive technologies in energy, electronics, technology, agriculture, and more.
No sector is off limits.
In just the past two years, I've brought investors explosive gains from companies in multiple sectors, such as:
- 1,667% on Lithium X (in 4 months)
- 530% on K92 Mining (in just 2 months)
- 437% on Golden Arrow (3 months)
- 619% on Brazil Resources (6 months)
- 306% on ImmunoPrecise (5 months)
- 212% on Emblem Corp (4 months)
- 211% on Golden Leaf Holdings (in just 1 week!)
- 241% on Ivanhoe Mines
- 339% on Almadex
- 296% on Lite Access Technologies
- 185% on Pioneering Technology (3 months)
- 253% on Skyharbor Resources (7 months)
- 192% on MedX Health (5 months)
- 153% on Captiva Verde (4 months)
- 159% on Golden Arrow Resources
- 391% on BYD Company (in 3 months)
- And many more.
In case you think I’m cherry picking these winners, every single play in my junior miner portfolio is up double and triple digits. The average gain is 118%. Check it out...
In fact, off of just one of my recommendations, you could make the type of money that could change your portfolio... or even your life.
How do I know? It’s already happened.
One guy by the name of Dan Leopold wrote to me about one of my recent recommendations...
"I made over $100,000 with you on the first run a year or so ago..."
I’ve had to redact the stock name there because it’s an active play that’s still making people money, and it wouldn’t be fair to those currently holding positions.
Donald McMillan shared his story, too:
"I did very well on two picks. Pretty lucky with a profit of $27,649!"
And Anthony Reymond recently wrote me to say:
"This is the most profitable service in almost 10 years of trading. Pure and simple. [Three picks] have been triple-digit winners for me. As a friend of mine who speaks broken English would say, 'THANK YOU VERY BIG.'"
But my favorite is from Tom Donaldson, who made nearly half a million dollars on a single trade:
"Nick — My account is now over $450,000. Happy with the gains so far! Thanks!"
So as you can see, I continually provide the potential for huge gains.
And I can tell you this...
It takes a lot of hard work and boots-on-the-ground research to maintain the success I’ve experienced.
Whether it’s flying out to the Nevada desert to get a firsthand look at the lithium that will supply our electric future while enriching shareholders...
Or walking the conference floor with company executives at the most prestigious investment shows in the country...
Or even interviewing Montel Williams in the hopes of discovering the next 1,000% gainer in the market...
I Spend Millions on My Research
I’ll go to any extent I feel necessary to make sure things are on the up and up before I recommend something other folks might put their money into.
I don’t simply sit behind a desk, stare at a computer screen, and pick a stock based on some arcane information from an annual report.
That’s for the no-talent hacks that think they know what they’re doing.
Not me. I do the real research most analysts don’t feel like doing — or can’t afford to do.
I’ve been in a three-man helicopter over the Canadian wilderness... stood on the edge of 500-foot-deep mines... and attended $5,000/seat conferences across the country... all in the name of securing the full stories behind the biggest wealth-creating opportunities in the world.
You can even say I’ve hobnobbed with the financial elite...
That’s me on the left. The "other guy" in that snapshot is John Paulson, American hedge fund guru and billionaire.
Not everyone can bend his ear at a private seaside dinner.
It’s pretty obvious these things don’t happen for analysts who refuse to leave the office — or get out of bed.
But I do it because it’s what I love to do. It’s what I’ve always loved to do.
Giving readers like YOU the early advantage on any moneymaking or money-saving opportunity available long before the rest of the market catches on.
That's what Early Advantage is all about.
I've been on the cutting edge for years, discovering major life-changing, moneymaking opportunities that other financial institutions don't cover.
Just to give you a better idea:
- Before the lithium boom took
off, I set up my readers with a company called Lithium X. It had huge
advantages over most lithium companies, including unparalleled
management in the sector. It also owned a proven deposit in the “Saudi
Arabia” of lithium: the brine salt triangle of Argentina. In just four
months, the stock surged from 15 cents to $2.50 — an earth-shattering
gain of 1,667%. And we booked the profits! That’s good enough to turn
just $10,000 invested into $166,700 in a few months.
- Before the November election,
when marijuana became legal in one dozen states, I set up an exclusive
deal for my readers with a small medical marijuana firm. This allowed us
to buy in literally days before the company’s IPO. In just eight days,
the company’s shares took off for 211% gains and we booked the profits.
That’s more than triple our money in just a week’s time!
- And I've closed, in total, more than 280 double- and triple-digit winners on my stock recommendations alone — and my portfolio’s win rate over the course of a decade is 83%!
My research comes with NO RISK and absolutely NO OBLIGATIONS.
For 30 days, you'll have the chance to profit from every single one of the winning investments I’ve shared exclusively with my followers... without risking a single dime.
I want you to see for yourself how potentially profitable Early Advantage really could be for you.
Simply put, the minute you claim your copy of “The FDA-Mandated Device: Earn 12,500% on The Technology That Ends Outbreaks," you'll immediately receive 30 full days of unrestricted access to the following:
- Quick Profits E-alerts:
Get flash updates on the latest moneymaking scoops from my profit
alerts. These obscure recommendations — that cannot wait a minute — will
be delivered straight to your inbox seconds after they're written, as
profitable opportunities could surface tomorrow.
- Regular Portfolio Updates:
You'll know exactly what's happening with each profit-making play in
your model portfolio, including regular updates and any news that will
send the stock soaring further or when to sell for maximum profits.
- The Members-Only Early Advantage Website:
Your gateway to my secure online platform for members only, with my
no-nonsense research reports, commentary, picks, and current portfolio.
You'll even get fast-track commentary on how to get the most out of my
- Research Videos:
You'll have full access to my boots-on-the-ground research videos when I
travel around the country investigating companies, visiting their
facilities, and talking to CEOs. That way, you can follow my travels
from your living room.
- Free Subscription: to the daily e-Letter Outsider Club and our special offers letter VIP Reserve.
Within minutes of signing up, you'll receive an email with your password to the Early Advantage website... your ultimate gateway to unheard-of profits in cutting-edge sectors, ahead of the crowd.
So how much does all this cost?
The short answer is: nothing.
I’ve convinced my publisher to give you a special deal... one that we’ve never offered before.
Now, I've seen research services like Early Advantage sell for $10,000 or more.
There are also "analysts" on Wall Street who pay thousands for these small-audience subscriptions.
Some of these analysts work in hidden niches of the market, making millions per year to research new ways to play upcoming trends.
To them, services like mine are a leg up on the competition, and they would happily pay $10,000 or more per year, since it’s really a fraction of the cost some "professionals" shell out for research like this.
But even though I could see this service going for that much, I know it would be difficult for everyday investors to participate at such high a price...
So I asked myself, What’s the absolute minimum I could ask people to pay for this service? What's reasonable? What's fair, considering the fundamental value?
After all, Angel Publishing and Outsider Club are in the publishing biz, and we have to keep the lights on here. That, and many of the companies I recommend with this predictive investment strategy require deep investigation.
That last part means I have to travel out to work sites... talk to the scientists and engineers... test the technology... and meet with the CEOs and other executives...
So after crunching the numbers, I finally settled on a price of $2,599 per year for this service. At least, that will be the regular price of this service moving forward.
It’s easy to understand why: One single recommendation could easily pay for your entire subscription.
For example, one of my followers, Chris G., recently sent me this note:
"Thanks Nick, I grabbed a quick 36% gain today. That'll take care of this year's subscription price!"Another of my followers, who wishes to remain anonymous, chimed in,
"I just renewed Early Advantage. Made $6,000 on one play, so my membership has more than paid for itself. Keep 'em coming!"Another one of my followers, Donald M., said he made a profit of $27,649 last year.
That’s enough to pay for 17 years of my research!
Todd S. is up a bit more, saying...
"Thanks to Early Advantage, I'm planning to retire a multimillionaire!"Given these kinds of gains, I'm sure you'll agree $2,599 is a bargain.
But you won’t have to pay that.
Reply Immediately and Receive
My "Charter Member" Pricing
As one of my invited subscribers, I’m prepared to offer you the entire Early Advantage subscription for just a fraction of the cost...
In fact, you’ll pay significantly less than others pay for 12 months of my profit alerts.
That’s a HUGE discount off the normal price!
Simply click the "Subscribe Now" button below to see your final pricing.
I truly believe this FDA-mandated technology is the single best opportunity I’ve discovered in 2017. I want to make absolutely sure you don't miss out on your chance to profit from it.
But there’s no telling how long this offer will be open, especially considering that this company is very small now but will be hitting the mainstream soon.
Even if we can at some point reopen this offer, it will likely only be to a handful of people and will probably come with the full price tag.
It’s a truly unique opportunity.
Because when I release my next alert, you could be up and running on your own path to becoming... well, much better off financially!
Subscribe at the end of this presentation to start receiving your Profit Alerts each month!
You're Minutes Away From Starting...
You simply cannot afford to not join my research service immediately.
Click the "Subscribe Now" button below to receive my latest alert, and you could be on your way to riding the biggest gains of your life.
And if you're still not convinced, you have 30 days to decide if my brand-new strategy is really right for you!
You have my personal guarantee...
My "Keep Everything & Risk Nothing"
You see, I stand behind every piece of advice, insight, and recommendation I make with 100% confidence. Your complete satisfaction is guaranteed — or your money back!
So I want you to go ahead and take a FULL 30 DAYS to have a good look at every breakout company I've uncovered.
And then, if for any reason you're not totally thrilled...
Just tell us to send your money back, and we'll promptly refund every penny, NO QUESTIONS ASKED.
You’ll get all the details about this FDA-mandated technology and the tiny 75-cent stock primed to soar. All the exclusive information on the members-only Early Advantage website. All the reports and investment guides. All the recommendations. All the articles and investing tips.
And if you join me today, I will give you access to three bonus reports — ABSOLUTELY FREE:
"The Tiny Company with Keys to Potentially Every Disease Known to Man"
"Virtual Reality Meets Real-World Dollars: The Small Company Set to Transform the $1.3 Trillion Construction Industry"
"Trump’s 'Nuclear Codes': How to Grab 33,798% Profits on the Coming Uranium Boom"
Some folks have shelled out $799 for EACH of these reports, but you won't pay a single cent for them.
All three bonus reports are yours FREE when you agree to test-drive Early Advantage for 30 full days starting right now.
The intel in just one of these special briefings could easily pay for your membership many times over...
And they're yours to keep — no matter what your final decision is. But you must act fast...
As you’ve seen, this technology is on the cusp of a historic mandated rollout. The opportunity is hot.
The tiny 75-cent stock with all the patents is on the verge of explosive, life-changing profits.
Already, it surged 174% after its IPO — and we’re just getting started.
On November 1, it will begin spreading to every restaurant, warehouse, and farm in America...
Quickly taking over a $20 billion market — and the FDA mandate guarantees it!
When that happens, major conglomerates will enter a fierce bidding war...
One that will send its shares to $5... $10... $25 — and beyond. All in no time flat.
Time is of the essence.
So you’ve seen the charts. You’ve seen the proof.
You’ve seen the wealth and money.
Here’s what I suggest you do right now...
Click here or the button below to get started right away.
You’ll be able to review everything on the next page before your order is final.
And remember, this offer is risk free for 30 days.
If you don’t like what you see, call us and cancel.
But if you’re still reading, I don’t think you'll need to worry, because I seriously doubt you'll be canceling...
Especially when you see what I’ve prepared for you.
So go ahead and start your own path to wealth. Click the link below.
Remember... your opportunity for incredible wealth could start immediately with my next alert.
I urge you to not delay.
I likely won't be able to offer this amazing deal to anyone else after this initial offer expires.
I look forward to the wealth we'll make together.
Just click below to get started...
Or if you’d prefer, call our VIP Support Desk toll-free at (844) 539-7664.
Call it like you see it,
Editor and Creator, Early Advantage